News

You are here

Oct 22, 2015

Next 2-6 November the first ECMED Workshop will take place. ECMED is the acronym for “The Extracellular Matrix in Epileptogenesis” a consortium formed by 11 organizations from all over Europe with a joint objective: to design, validate and bring into practice new innovative therapeutic strategies against epilepsy. The first workshop, entitled “Understanding epilepsy and Practical workshop 1” will be held in Magdeburg, Germany. Delegates from the consortium members will gather together in order to delve into epilepsy.

Oct 22, 2015

Roger Prades, Iproteos CSO will participate at the Barcelona BioMed Conference “Blood Brain Barrier” that will be held next November 2-4. Roger will give a short talk that will be entitled “IPR19: a prolyl oligopeptidase inhibitor for the treatment of cognitive impairment associated with schizophrenia”. The talk will be delivered on Thursday 3 in the afternoon, at the “Institut d’Estudis Catalans”. This Barcelona BioMed Conference is organized by Prof. Ernest Giralt (IRB Barcelona, Spain) and Prof.

Sep 10, 2015

From 29/08 to 1/09, Roger Prades, Iproteos CSO, participated at the 28th ECNP Congress of Applied and Translational Neuroscience. His abstract was selected for poster oral presentation, which was given on 30th of August. “It has been a very positive experience. Lots of scientists and physicians came around the poster to know a little bit more about IPR19, the cognitive enhancer we are developing at Iproteos”, has declared Roger after the ECNP Congress.

Sep 10, 2015

Teresa Tarragó will participate at the Innovation Days 2015, a partnering meeting in Open Innovation for Life Sciences. It will take place from 5-6 of October and it is held in Paris. The event features conferences and workshops together with one-to-one partnering meetings. Iproteos CEO will be on Tuesday 6th of October seeking for partnerships and business opportunities. You can know more about our pipeline, and the potential of the IPROTech in this web.

Sep 10, 2015

On 5th of October 2015, Teresa Tarragó, Iproteos CEO, will give the Keynote Lecture at the 2nd CRG BioBusiness School. The 5-day course is aimed to go deep into the Tech Transfer at Science a key aspect in the world of biotech. Participants will learn how to identify projects with potential to be transferred to a company or to create a spin-off. Besides, students will generate their very own business model and will have the opportunity to present it in font of experts that will give them their feedback.

Aug 25, 2015

Teresa Tarragó will attend next Boulder Peptide Symposium 2015 (BPS 2015), which will be held in Denver (Colorado) from 28th September to the 1st of October. Her abstract entitled “IPRO Technology: a platform for the discovery of therapeutic peptidomimetics”, has been selected for the Peptide Showcase, an opportunity to expose the latest and novel ideas, technologies and pipeline assets.